QNCX NASDAQ
Quince Therapeutics, Inc.
1W: -5.8%
1M: -9.2%
3M: +72.0%
YTD: +873.3%
1Y: +1702.5%
3Y: +2395.7%
5Y: -68.8%
$29.20
-1.48 (-4.82%)
Weekly Expected Move ±10.0%
$23
$26
$29
$32
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — QNCX
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (21)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 57.7 | 63.2 | 61.6 | 60.8 | SEC ↗ |
| 2026-03-31 | 10-Q | 61.2 | 74.0 | 68.0 | 67.7 | SEC ↗ |
| 2025-12-31 | 10-K | 52.2 | 64.9 | 60.1 | 59.1 | SEC ↗ |
| 2025-09-30 | 10-Q | 72.1 | 73.1 | 72.8 | 72.6 | SEC ↗ |
| 2025-06-30 | 10-Q | 72.1 | 72.4 | 69.3 | 71.3 | SEC ↗ |
| 2025-03-31 | 10-Q | 65.9 | 69.4 | 68.5 | 68.0 | SEC ↗ |
| 2024-12-31 | 10-K | 60.3 | 63.5 | 63.6 | 62.5 | SEC ↗ |
| 2024-09-30 | 10-Q | 60.2 | 63.7 | 65.0 | 63.0 | SEC ↗ |
| 2024-06-30 | 10-Q | 60.3 | 62.3 | 64.5 | 62.3 | SEC ↗ |
| 2024-03-31 | 10-Q | 60.5 | 62.6 | 64.8 | 62.6 | SEC ↗ |
| 2023-12-31 | 10-K | 60.5 | 62.9 | 64.0 | 62.5 | SEC ↗ |
| 2023-06-30 | 10-Q | 61.9 | 60.4 | 60.6 | 61.0 | SEC ↗ |
| 2023-03-31 | 10-Q | 60.8 | 60.2 | 60.5 | 60.5 | SEC ↗ |
| 2022-12-31 | 10-K | 57.1 | 61.2 | 61.8 | 60.0 | SEC ↗ |
| 2022-09-30 | 10-Q | 56.1 | 60.2 | 59.6 | 58.6 | SEC ↗ |
| 2022-06-30 | 10-Q | 55.5 | 61.7 | 59.5 | 58.9 | SEC ↗ |
| 2021-12-31 | 10-K | 56.0 | 60.6 | 62.0 | 59.6 | SEC ↗ |
| 2021-09-30 | 10-Q | 55.7 | 59.4 | 59.9 | 58.4 | SEC ↗ |
| 2020-12-31 | 10-K | 54.9 | 60.9 | 61.7 | 59.2 | SEC ↗ |
| 2020-09-30 | 10-Q | 46.0 | 57.8 | 55.8 | 53.2 | SEC ↗ |
| 2020-06-30 | 10-Q | 40.1 | 57.5 | 56.9 | 51.5 | SEC ↗ |